Integral Diagnostics
Integral Diagnostics, a leading provider of diagnostic imaging services, is headquartered in Australia and operates extensively across major regions including Queensland, Victoria, and Western Australia. Founded in 2006, the company has established itself as a key player in the healthcare sector, focusing on high-quality radiology services. Specialising in a range of imaging modalities such as MRI, CT, and ultrasound, Integral Diagnostics is recognised for its commitment to advanced technology and patient care. The company’s unique approach combines state-of-the-art equipment with a team of highly skilled professionals, ensuring accurate and timely diagnoses. With a strong market position, Integral Diagnostics has achieved significant milestones, including numerous accreditations and partnerships that enhance its service offerings. As a trusted name in the industry, Integral Diagnostics continues to set benchmarks for excellence in diagnostic imaging.
DitchCarbon Score
How does Integral Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Integral Diagnostics's score of 2 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Integral Diagnostics's reported carbon emissions
In 2022, Integral Diagnostics reported total greenhouse gas emissions of approximately 5,899,600 kg CO2e, comprising 588,100 kg CO2e from Scope 1 and 9,109,500 kg CO2e from Scope 2 emissions. This marked an increase from 2021, where emissions were about 5,780,000 kg CO2e, with 508,200 kg CO2e from Scope 1 and 7,028,800 kg CO2e from Scope 2. In 2020, the company recorded emissions of around 7,098,200 kg CO2e, with 432,700 kg CO2e from Scope 1 and 6,716,500 kg CO2e from Scope 2. For 2023, no emissions data has been disclosed, indicating a potential shift in reporting or data collection practices. Integral Diagnostics has not set specific reduction targets or climate pledges, which may reflect a broader industry context where many organisations are still developing comprehensive climate strategies. The company continues to monitor its emissions per patient exam, with Scope 1 emissions at approximately 0.3 kg CO2e and Scope 2 emissions at about 3.5 kg CO2e per exam in 2023. Overall, while Integral Diagnostics has made strides in tracking its emissions, the absence of reduction targets suggests an opportunity for further commitment to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 432,700 | 000,000 | 000,000 |
| Scope 2 | 6,716,500 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Integral Diagnostics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
